190 related articles for article (PubMed ID: 9671117)
21. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.
Tanaka H; Shigenobu K
Cardiovasc Drug Rev; 2002; 20(1):81-92. PubMed ID: 12070536
[TBL] [Abstract][Full Text] [Related]
22. The voltage-dependent non-selective cation channel sensitive to the L-type calcium channel blocker efonidipine regulates Ca2+ influx in brain vascular smooth muscle cells.
Matsuoka T; Nishizaki T; Nomura T
Biochem Biophys Res Commun; 1997 Nov; 240(2):484-7. PubMed ID: 9388505
[TBL] [Abstract][Full Text] [Related]
23. Relative selectivity for negative chronotropic and inotropic effects of a novel dihydropyridine derivative CD-832.
Noguchi K; Masumiya H; Sasaki T; Takahashi K; Araki H; Higuchi S; Tanaka H; Shigenobu K
Eur J Pharmacol; 1996 Jul; 308(1):53-9. PubMed ID: 8836632
[TBL] [Abstract][Full Text] [Related]
24. [Effect of efonidipine hydrochloride on myocardial oxygen balance in anesthetized dogs].
Fujikura N; Yokoyama T; Masuda Y; Shikada K; Tanaka S
Nihon Yakurigaku Zasshi; 1996 Aug; 108(2):39-48. PubMed ID: 8827722
[TBL] [Abstract][Full Text] [Related]
25. Spasmolytic effect of efonidipine hydrochloride in isolated canine coronary artery: comparison with the effects of nifedipine and nisoldipine.
Jin H; Sato R; Higashino R; Fukuda Y; Kurimoto T; Tamaki H
Biol Pharm Bull; 1997 Feb; 20(2):196-200. PubMed ID: 9057986
[TBL] [Abstract][Full Text] [Related]
26. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells.
Imagawa K; Okayama S; Takaoka M; Kawata H; Naya N; Nakajima T; Horii M; Uemura S; Saito Y
J Cardiovasc Pharmacol; 2006 Jan; 47(1):133-8. PubMed ID: 16424797
[TBL] [Abstract][Full Text] [Related]
28. [Effect of efonidipine hydrochloride (NZ-105), a dihydropyridine derivative with calcium antagonistic action, on myocardial oxygen tension in anesthetized dogs].
Fujikura N; Yokoyama T; Masuda Y; Shikada K; Tanaka S
Nihon Yakurigaku Zasshi; 1996 Nov; 108(5):267-74. PubMed ID: 8974087
[TBL] [Abstract][Full Text] [Related]
29. Histamine H1-receptor-mediated increase in the Ca2+ transient without a change in the Ca2+ current in electrically stimulated guinea-pig atrial myocytes.
Yoshimoto K; Hattori Y; Houzen H; Kanno M; Yasuda K
Br J Pharmacol; 1998 Aug; 124(8):1744-50. PubMed ID: 9756392
[TBL] [Abstract][Full Text] [Related]
30. Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo.
Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Takamatsu I; Ozawa Y; Saruta T
J Hypertens; 2001 Nov; 19(11):2031-7. PubMed ID: 11677369
[TBL] [Abstract][Full Text] [Related]
31. Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.
Harada K; Nomura M; Nishikado A; Uehara K; Nakaya Y; Ito S
Circ J; 2003 Feb; 67(2):139-45. PubMed ID: 12547996
[TBL] [Abstract][Full Text] [Related]
32. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T
Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
[TBL] [Abstract][Full Text] [Related]
33. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604
[TBL] [Abstract][Full Text] [Related]
34. Effects of inhibition of calcium and potassium currents in guinea-pig cardiac contraction: comparison of beta-caryophyllene oxide, eugenol, and nifedipine.
Sensch O; Vierling W; Brandt W; Reiter M
Br J Pharmacol; 2000 Nov; 131(6):1089-96. PubMed ID: 11082115
[TBL] [Abstract][Full Text] [Related]
35. Beneficial effects of the dual L- and T-type Ca2+ channel blocker efonidipine on cardiomyopathic hamsters.
Suzuki S; Ohkusa T; Ono K; Sato T; Yoshida MA; Yano M; Takebayashi S; Matsuzaki M
Circ J; 2007 Dec; 71(12):1970-6. PubMed ID: 18037756
[TBL] [Abstract][Full Text] [Related]
36. Comparative effects of oxodipine and nifedipine in the isolated guinea-pig heart.
Tejerina T; Delgado C; Valenzuela C; Tamargo J
Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):186-99. PubMed ID: 3675081
[TBL] [Abstract][Full Text] [Related]
37. Voltage- and frequency-dependent modulation of L-type Ca2+ channel by MPC-1304, a novel calcium antagonist in guinea-pig hearts.
Sunami A; Kanno T; Kanda A
Arch Int Pharmacodyn Ther; 1995; 330(2):151-64. PubMed ID: 8861709
[TBL] [Abstract][Full Text] [Related]
38. Effects of gallopamil, nifedipine, Ni2+, and La3+ in guinea pig atria after a sudden increase in extracellular Ca2+ concentration.
Ravens U; Steinmann E; Ziegler A
J Cardiovasc Pharmacol; 1987 Oct; 10(4):462-73. PubMed ID: 2444801
[TBL] [Abstract][Full Text] [Related]
39. Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels.
Furukawa T; Miura R; Honda M; Kamiya N; Mori Y; Takeshita S; Isshiki T; Nukada T
Br J Pharmacol; 2004 Dec; 143(8):1050-7. PubMed ID: 15545287
[TBL] [Abstract][Full Text] [Related]
40. Beneficial effect of T-type calcium channel blockers on endothelial function in patients with essential hypertension.
Oshima T; Ozono R; Yano Y; Higashi Y; Teragawa H; Miho N; Ishida T; Ishida M; Yoshizumi M; Kambe M
Hypertens Res; 2005 Nov; 28(11):889-94. PubMed ID: 16555577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
